UAE Doctors Warn About Risks of Taking Supplements That The Body Does Not Need
Read more
Khaleej Times
www.khaleejtimes.com

UAE Doctors Warn About Risks of Taking Supplements That The Body Does Not Need

As temperatures moderate and outdoor activities become more feasible, residents of the United Arab Emirates (UAE) are resuming their sports routines, participating in competitions, and increasing training intensity. For many, returning to physical activity also means reassessing diet and recovery regimens. Protein powders, multivitamins, magnesium, and electrolyte supplements are increasingly found in gym bags, as some rely on them to boost endurance, build muscle mass, and replenish nutrients after workouts.

However, doctors strongly urge caution, stating that an active lifestyle alone is not grounds for starting supplementation. Without knowing about actual nutrient deficiencies, adding products to the daily diet can do more harm than good.

Medical professionals note that some residents choose supplements based on recommendations from gyms, friends' advice, or social media trends, rather than seeking medical consultation to determine their body's needs.

Dr. Mohammed Elgezouli, a family medicine specialist at Sheikh Sultan Bin Zayed Hospital in Al Bateen, Sharjah, reported that it has become common for patients to come in taking multiple products simultaneously. He noted: 'Many patients come in taking several products at once, such as protein powder, multivitamins, magnesium, and electrolytes, usually based on advice from friends, trainers, or social media, rather than after a blood test.'

He added that most people adhering to a balanced diet do not require many of these products, although Vitamin D is a significant point in the UAE. 'Vitamin D is the main exception in the UAE, but even that should be confirmed by testing.'

Doctors emphasize that one of the most common misconceptions among fitness enthusiasts is the belief that supplements labeled as natural or safe cannot cause harm. Dr. Elgezouli warned that excessive intake of certain nutrients can have serious consequences, especially if the products are taken long-term without medical supervision.

'High doses of Vitamin D over a long period can increase calcium levels and damage the kidneys. Iron, taken without deficiency, can accumulate in organs. Magnesium and potassium can reach dangerous levels in people with undiagnosed kidney problems,' he stated.

He also warned that supplements can interact with prescribed medications, including anticoagulants and thyroid tablets. It has been found that some fitness products sold online contain hidden stimulants or steroids.

Confirming these concerns, Swapna Mary John, a clinical dietitian at the International Modern Hospital in Dubai, noted that the growing popularity of supplements during the fitness season in the UAE does not mean they are necessary for everyone. She said: 'Many people assume that regular exercise means they need extra supplements. However, a balanced diet often provides everything the body needs. Supplements should address specific nutritional needs, not just follow fitness trends.'

John also pointed out potential risks of overuse, including nerve damage from high doses of Vitamin B6 and kidney damage from excess Vitamin D. 'Combining supplements can also lead to unintentional overdose or drug interactions. More is not always better, and unnecessary extra nutrition can sometimes do more harm than good.'

Dr. Mariane Malak Eshak Markos, a family medicine specialist at Burjeel Surgical Center in Al Shaham, advised residents to be particularly cautious in assuming that products advertised as natural are automatically harmless. She stated: 'Overuse of supplements can potentially lead to health complications. For example, too much Vitamin D can lead to elevated calcium levels, while unnecessary iron supplementation can cause digestive issues and, in some cases, organ damage.'

She added that taking multiple products together can increase the risk of exceeding recommended daily allowances or interacting with prescribed medications. 'Therefore, self-prescribing supplements for a long time is generally not recommended.'

Instead of following fitness trends or copying someone else's supplement regimen, doctors recommend assessing individual nutritional needs before introducing additional products. Dr. Elgezouli advised residents to consult a doctor and undergo appropriate tests to establish any deficiencies. 'Basic tests include a complete blood count, iron stores, Vitamin D, Vitamin B12, kidney function, blood sugar and cholesterol levels, as well as thyroid tests if symptoms are present.'

He also added that people over 40 or those with cardiovascular risk factors should undergo a cardiology check-up before starting intense training. The results will help doctors determine the need for supplements, considering the person's diet, age, medical history, medications, and training intensity.

John noted that the assessment should also consider dietary habits, level of physical activity, and any symptoms before supplements are recommended. 'Protein needs can often be met through food, while electrolytes are usually more beneficial during prolonged exercise with heavy sweating.'

For residents engaging in outdoor sports, especially in the warmer months of the UAE, hydration remains important. However, electrolyte products should not automatically become part of everyone's daily diet. Dr. Markos also stressed that supplement recommendations must be based on an individual's nutritional gaps, not on general advice circulating online or in fitness communities. 'Before starting supplements, people should consider a medical evaluation that takes into account their dietary habits, training routine, age, existing conditions, and current medications.'

Depending on the results, medical staff may recommend tests such as Vitamin D, Vitamin B12, and iron levels. 'The goal is to identify actual deficiencies or nutritional gaps, not to take supplements by trial and error. A personalized approach is always safer and more effective than following general guidelines,' Markos concluded.

}))

Similar stories

UAE Doctors Warn: Weight Loss with Injectable Drugs May Lead to Muscle Mass Loss, Not Just Fat
Read more
www.khaleejtimes.com

UAE Doctors Warn: Weight Loss with Injectable Drugs May Lead to Muscle Mass Loss, Not Just Fat

Although the goal of people resorting to popular injectable drugs for weight loss is often to reduce body mass, doctors from the United Arab Emirates warn that the number on the scale does not tell the whole story. Specialists note that when using medications such as Mounjaro, Ozempic, and Wegovy, patients should pay attention not only to excess fat but also to the loss of muscle tissue, which is critically important for maintaining strength, mobility, and long-term health.

Risks can increase in patients who significantly reduce food intake while taking these medications, especially if they suffer from protein deficiency, dehydration, or insufficient physical activity. The medical community emphasizes that the main objective should not just be rapid weight loss, but improving metabolic health while preserving muscle strength and physical functions.

Dr. Niyas Khalid, an internal medicine specialist at Burjeel Hospital in Abu Dhabi, stated: 'Never assess weight loss solely by the scale.' He clarified that before starting treatment, doctors conduct a comprehensive assessment of the patient's overall obesity profile, including metabolic status, relevant blood tests, nutritional status, and body composition.

'We collaborate closely with dietitians and nutritionists who assess body composition, often using bioelectrical impedance analysis (such as InBody) to determine fat and muscle mass. Periodic re-evaluations during treatment help us understand whether weight loss is primarily due to fat or includes excessive loss of muscle tissue. We also consider physical strength, functional capabilities, and weight loss rates,' added Dr. Khalid.

He also warned patients that rapid weight loss can be accompanied by muscle loss, especially with inadequate nutrition and physical activity. It is important to distinguish between fat loss and muscle mass loss, as the loss of muscle tissue can negatively affect physical functions, especially in the elderly and those already at risk of muscle weakness.

Dr. Amna Kiran, an endocrinologist at the International Modern Hospital in Dubai, reported that Mounjaro (tirzepatide), Ozempic, and Wegovy (semaglutide) are among the most common and recognized medications in the UAE, with Mounjaro being particularly popular due to its high effectiveness in weight loss. According to Dr. Kiran, 'an observational study in the UAE showed that Mounjaro accounted for 65.6 percent of GLP-1 based prescriptions in the studied cohort in 2024.'

However, she stressed that weight loss does not always indicate the amount of lost muscle mass, so adequate monitoring is necessary. In her regular practice, Dr. Kiran uses body weight measurement, waist circumference, and simple muscle function tests, including grip strength. While BIA can help track body composition trends, its accuracy depends on hydration and other factors. For a more precise assessment, especially in patients at risk of significant muscle loss, she prefers Dexa scanning.

Dr. Kiran also cited the results of the Surmount-1 subgroup study, which examined changes in body composition during tirzepatide treatment. 'The Surmount-1 subgroup study found that approximately 75 percent of the lost weight was fat mass, and 25 percent was muscle mass; importantly, muscle mass loss does not necessarily mean equivalent loss of skeletal muscle.' She explained that muscle mass includes more than just skeletal muscles, and measurements can be distorted by factors such as hydration levels. Therefore, doctors insist on interpreting body composition analysis results alongside clinical examinations, rather than equating every loss of muscle mass to a loss of muscle.

One of the mechanisms of action of these drugs is appetite suppression. Nevertheless, a significant reduction in food intake can make it difficult to meet the body's nutritional needs, especially if meals are skipped or consumption of protein-rich foods is ignored. Dr. Khalid noted that some patients eat significantly less than required, including protein deficiency, while others reduce fluid intake due to nausea or other gastrointestinal side effects.

He advised patients to include protein-rich foods in their diet, such as eggs, fish, lean meat, dairy products, and legumes, with individual nutrition plans developed after consulting with dietitians. Maintaining adequate hydration throughout the treatment course is also recommended. Protein and fluid needs vary depending on body composition, age, kidney function, and other clinical factors.

Furthermore, physical activity must become part of a structured weight management plan. The World Health Organization recommends at least 150 minutes of moderate physical activity per week, but these figures must be adapted to each patient's health condition and physical capabilities.

Dr. Kishan Delampadi, a consultant endocrinologist at NMC Royal Hospital Sharjah, stated that the growing popularity of these drugs should not dictate the decision to take them. He explained that these medications work by influencing appetite and satiety, helping people reduce their food intake. However, they are not suitable for everyone, and the choice depends on weight, medical history, existing conditions, medications being taken, and the person's treatment goals.

He also cautioned patients against using prescription drugs simply because someone they know achieved good results, emphasizing the need to differentiate between drugs approved for diabetes treatment and those intended for weight control. According to him, medical evaluation, a proper prescription, and regular monitoring are mandatory, and the medications should complement, not replace, a balanced diet, physical activity, and behavioral changes.

Dr. Delampadi added that side effects such as nausea, vomiting, diarrhea, or constipation can affect hydration and nutrient intake if they persist for a long time. This is especially important with age, as muscle mass and strength naturally decline. Rapid weight loss combined with poor nutrition and a sedentary lifestyle can complicate the maintenance of independence. Even young adults should take care of their muscles, rather than focusing solely on appearance or clothing size.

UAE Authorities Urge Residents to Report Drug Side Effects as Part of Medication Safety Campaign
Read more
www.khaleejtimes.com

UAE Authorities Urge Residents to Report Drug Side Effects as Part of Medication Safety Campaign

Residents of the United Arab Emirates (UAE) who suspect side effects after taking medications are strongly advised to report them to the relevant health authorities. This is part of a nationwide initiative aimed at enhancing medication safety levels.

The Emirates Drug Authority (EDA) has launched a campaign titled 'Speak Up .. Stay Safe.' This campaign is conducted in collaboration with five health authorities and calls on patients, caregivers, and healthcare professionals to share information about possible adverse reactions.

The campaign was announced on Wednesday, November 4th, and is part of the global MedSafetyWeek 2026, which runs from November 2nd to 8th. Authorities emphasized that reporting suspected side effects helps identify potential safety issues requiring further investigation, even if the drug has already received marketing approval.

Residents can use the EDA's DAWA intelligent tool to register suspected side effects of medicines and other medical products. This tool simplifies the process of submitting experiential information, after which reports are forwarded to specialists for assessment according to established procedures.

The tool was developed and approved through a partnership between EDA and the Uppsala Monitoring Centre and supports continuous monitoring of drugs available on the market. EDA also strongly recommended that patients, caregivers, and healthcare professionals utilize official reporting channels.

Dr. Ruqaiya Aqeel Al Bastaki, Executive Director of the Medical Products Regulatory Sector at EDA, noted that drug safety monitoring does not cease after a product receives approval and enters the market. She explained that responsibility remains throughout the entire lifecycle of the drug, as new information regarding its impact on patients continues to emerge.

Reports provided by residents and healthcare professionals are analyzed alongside other scientific data. This information allows authorities to identify potential danger signals that require deeper investigation. According to Al Bastaki, an effective drug safety control system depends on cooperation among regulatory bodies, healthcare professionals, pharmaceutical companies, patients, and caregivers.

She also stressed that reporting should become an integral part of responsible drug use, rather than being limited only to informational campaigns. The nationwide campaign unites EDA, the Ministry of Health and Prevention, the Emirates Health Services, Dubai Health Authority, Abu Dhabi Department of Health, and Sharjah Health Authority.

This year's MedSafetyWeek is running under the slogan: 'Don't Ignore Side Effects, Report Them!' This initiative, now in its 11th edition, is coordinated by the Uppsala Monitoring Centre in collaboration with drug regulators, monitoring centers, and international organizations.

As part of the campaign, virtual seminars will be organized for healthcare professionals to enhance their understanding of drug safety monitoring and managing suspected adverse effects. Awareness events will also take place at the University of Sharjah, where students will attend lectures on pharmacovigilance, the drug safety monitoring process, and receive training on using official reporting channels.

A dedicated webinar for pharmaceutical companies will explain their obligations and requirements for drug safety monitoring. This guide defines the responsibilities of relevant organizations and the requirements for monitoring safety information and managing risks associated with drugs after they have received marketing authorization.

NYU Abu Dhabi study shows economic benefits of weight-loss drugs like Wegovy and Ozempic
Read more
www.khaleejtimes.com

NYU Abu Dhabi study shows economic benefits of weight-loss drugs like Wegovy and Ozempic

According to a new study conducted by NYU Abu Dhabi, medications for diabetes treatment and weight management, including Ozempic and Wegovy, may bring economic benefits that extend beyond improving patient health. It was found that the use of these treatments is associated with increased employment and longer working hours.

Researchers used nationwide data from Denmark and found that people receiving treatment for type 2 diabetes were more likely to be employed, while those taking weight management drugs increased their working hours if they were already employed.

The study examined two drugs: semaglutide, marketed as Ozempic (for type 2 diabetes) and Wegovy (for weight control). Both medications belong to the GLP-1 receptor agonist class, which mimics the natural hormone regulating appetite and blood sugar levels.

The analysis was based on Danish population records from 2018 to 2024, examining changes in earnings, working hours, and employment before and after patients began therapy. Statistical methods were used to separate the effects of the treatment itself from general labor market changes.

Among patients receiving subsidized Ozempic treatment for diabetes, it was found that the therapy increased the probability of employment by 4.1 percentage points. Furthermore, this group demonstrated an increase in working hours by 19.5 hours per quarter.

However, the results were different for patients who self-paid for Wegovy to correct their weight. Although the drug did not lead to a significant increase in the probability of employment, those who were already employed increased their workload by an additional 29.7 hours per quarter.

Weda Narasimhan, Assistant Professor of Economics at NYU Abu Dhabi, noted that this data underscores the need to consider the broader economic impact of medications, not just the direct costs. She added that separating employment and working hour analyses allows for a better understanding of the differences in outcomes between treatment groups and potential consequences for individuals and public finances.

Beyond employment issues, scientists investigated whether increased working hours and income could generate additional income through income tax and help offset public healthcare expenditures. In Denmark, Ozempic treatment for diabetes is subsidized, whereas patients using Wegovy for weight control pay the full cost themselves.

According to the study's fiscal analysis, the additional income from income tax related to increased earned income among patients taking these drugs could help cover public expenses for subsidized diabetes treatment.

Raul Santaeulalia-Llopis, an economics lecturer at NYU Abu Dhabi, stated that medical procedures should not be evaluated solely on their clinical outcomes. He emphasized that evaluating only metrics such as weight loss or blood sugar levels overlooks the broader picture, requiring consideration of factors beyond direct medical costs.

He noted that the study shows that when changes in employment, working hours, and subsequent tax revenues are taken into account, the financial calculation changes drastically. Nevertheless, Santaeulalia-Llopis stressed that understanding the broader influence of these drugs requires studying whether they contribute to sustainable lifestyle changes.

He questioned whether GLP-1 is a catalyst for a healthier and self-sustaining lifestyle, or if its economic dividends merely create a new form of pharmaceutical dependence. Santaeulalia-Llopis reported that current research with the Abu Dhabi Department of Health under the Thiqa obesity program is focused on this question.

The findings were published as a discussion paper by the Center for Economic Policy Research (CEPR). By analyzing diabetes treatment and weight control separately, the researchers highlighted how the economic effects of semaglutide can vary depending on the patient's health status, employment status, and method of financing the treatment. The study also suggests that assessing the broader economic impact of such drugs can help policymakers better understand their potential consequences for public finances and healthcare spending.

Popular